AuntMinnieEurope.com staff writersRadiation Oncology/TherapySiemens to invest €70 million to expand site in GermanySiemens HealthineersThe hall will have a total floor area of about 4,500 square meters, including 3,400 square meters of production space for radiotherapy components.July 15, 2026Womens ImagingQuibim launches AI breast MRI tool across Europe, UKQuibimThe tool, QP-Breast, highlights suspicious areas on MRI and generates reports from imaging findings.July 2, 2026Molecular ImagingGE HealthCare, University Hospital Essen open nuclear medicine centerGE Healthcare - EUThe center features the first installation of GE HealthCare's StarGuide GX SPECT/CT scanner.July 1, 2026CTMedneo acquires Ramsay Diagnostics UK mobile imaging fleetMedneo is acquiring Ramsay Diagnostics UK's mobile MRI and CT fleet and a six-year contract to provide mobile imaging services.June 30, 2026UltrasoundCanon Medical, Fraiya partner for AI prenatal ultrasound in EuropeCanon Medical Systems Europe B.V.Imaging focuses on the mid-trimester anomaly scan.June 26, 2026Enterprise ImagingSectra signs enterprise imaging deal with German radiology groupSectra has signed a 10-year enterprise imaging contract with MVZ MedDiagnost.June 25, 2026UltrasoundBrightHeart receives CE mark for prenatal ultrasound AI platformThe CE mark follows an €11 million series A funding round.June 24, 2026UltrasoundCanon unveils Aplio me X ultrasound system at Euroson 2026Canon Medical Systems unveiled its Aplio me X diagnostic ultrasound system at Euroson 2026.June 18, 2026Enterprise Imaging15 NHS trusts begin procurement for shared imaging platformWest Midlands regional initiative expected to reduce costs of individually managed contracts.June 16, 2026Molecular ImagingSiemens Healthineers announces U.K. radiopharmacy expansion in DunstableSiemens HealthineersInvestment supports increased output and same-day delivery of PET radiopharmaceuticals and theranostics agents.June 16, 2026Previous PagePage 5 of 962Next PageTop StoriesMolecular ImagingSPECT-guided algorithm can aid in assessing Lu-177 RPT responsesCurrently, there is no standardized approach for deciding when to continue or discontinue Lu-177 PSMA therapy after initial cycles.Nuclear MedicineHybrid imaging experts weigh diagnostic gains against unnecessary scans at CHILI 9.0Digital X-RayWhy conventional x-rays still matter in arthritis imagingNuclear Medicine25th-anniversary PET/CT: USZ's Hüllner on clinical innovation and adoptionCTLung-RADS may speed diagnosis of cystic airspace lung cancer